Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 35 (3) , 259-273
- https://doi.org/10.1023/a:1005812417638
Abstract
No abstract availableThis publication has 95 references indexed in Scilit:
- Phase I studies of treatment of malignant gliomas and neoplastic meningitis with131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab?)2-a preliminary reportJournal of Neuro-Oncology, 1995
- Prognostic relevance of epidermal growth factor receptor (EGF-R) and c-neu/erbB2 expression in glioblastomas (GBMs)Journal of Neuro-Oncology, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unitCell, 1992
- Isolation of the NeuHER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cellsCell, 1992
- Deletion-mutant epidermal growth factor receptor in human gliomas: Effect of type II mutation on receptor functionBiochemical and Biophysical Research Communications, 1991
- Antiproliferative effect of trapidil, a platelet-derived growth factor antagonist, on a glioma cell line in vitroJournal of Neurosurgery, 1990
- Interactions between growth factor receptors and corresponding monoclonal antibodies in human tumorsJournal of Cellular Biochemistry, 1987
- Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodiesCell, 1985